Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pathology and Laboratory Medicine, |
RCV001356796 | SCV001552061 | pathogenic | Familial ovarian cancer | no assertion criteria provided | clinical testing | The ATM p.Ile1559Leufs*35 variant was not identified in the literature nor was it identified in the dbSNP, ClinVar, COGR, Cosmic, LOVD 3.0, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.4674_4695del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1559 and leads to a premature stop codon at position 1593. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the ATM gene are an established mechanism of disease in ATM associated cancers and is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. |